Plus, news about Incyte, Evommune, Kainova and Sutro:
📊 Nektar outlines one-year eczema data: The company said its drug rezpegaldesleukin, commonly known as rezpeg, maintained and deepened patients’ skin clearances after a 52-week follow-up period ...
↧